Pages
Products
Support
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

SK-BR-3 Cell Line

General Information
OrganismHomo sapiens, human
Cell Line DescriptionSK-BR-3 (also known as SkBr3) is a human breast cancer cell line isolated in 1970 at Memorial Sloan-Kettering Cancer Center for use in therapeutic research, specifically HER2-targeted therapy. SK-BR-3 cells were derived from pleural effusion arising from adenocarcinoma in a 43-year-old white woman. The cell line harbors genetic aberrations commonly seen in breast cancer, including HER2 gene amplification and mutations in the p53 tumor suppressor gene. Overexpression of HER2 in SK-BR-3 cells makes it a valuable model for studying HER2-positive breast cancer, which is characterized by aggressive growth and poor prognosis, as well as HER2-targeted therapies. SK-BR-3 cells played an important role in the study of trastuzumab (Herceptin), a monoclonal antibody directed against HER2 that has become a cornerstone of treatment for HER2-positive breast cancer.
TissueBreast, mammary gland
DiseaseInvasive ductal carcinoma
MorphologyEpithelial-like
GenderFemale
Age43 years
Product FormatFrozen
Growth ModeAdherent
Biosafety Level1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Applications1. Drug testing
2. Genetic studies
3. Protein research
4. Herceptin research
5. Pathway analysis
Shipped inDry ice
Storage Temperature−196°C
Additional InfoThe SK-BR-3 cell line is autologous (derived from the same patient) to the AU565 cell line. These cells are considered biosafety level 1. They are known to grow in grape-like clusters and have an invasive phenotype similar to cells in vivo. SK-BR-3 cells have been used in studies seeking to overcome Herceptin therapeutic resistance in HER2-overexpressing breast cancer. The cell line has also been tested for applications such as CRISPR/Cas9 gene editing, antibody resistance in transfection, and HER2-based cancer therapy in the context of microenvironmental fluctuations.
Characteristics
KaryotypeThis is a hypertriploid human cell line with a modal chromosome number of 84, present in 34% of the cells. Cells with 80 chromosomes were also present in a high proportion (28%); the proportion of higher ploidy cells was 7.3%. This cell line has a very complex chromosomal composition. Between 35% and 40% of the chromosomes in the complement of cells with a chromosome mode of 84 consist of structurally altered marker chromosomes. Several markers are longer than chromosome N1.
Protein Expressionp53 positive
Antigen ExpressionBlood Type A, Rh+, HLA A11, Bw22(+/-), B40, B18
TumorigenicYes, in nude mice, forms poorly differentiated adenocarcinoma
Mycoplasma TestNegative
Culture Conditions and Handling
Subculturing1. Remove old culture medium from adherent cells and wash with calcium- and magnesium-free PBS. For T25 flasks, use 3-5 ml of PBS and for T75 flasks, use 5-10 ml.
2. Then, completely cover the cells with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks.
3. Allow cells to detach by incubating at room temperature for 8-10 minutes.
4. After incubation, resuspend cells by gently mixing with 10 ml of medium and centrifuge at 300xg for 3 minutes.
5. Discard the supernatant, resuspend the cells in fresh medium, and transfer them to a new flask that already contains fresh medium.
Medium Renewal2 to 3 times per week
Subcultivation RatioThe ratio of 1:2 to 1:4 is recommended.
Culture MediumDMEM supplemented with 4.5g/L glucose, 1.5 mM L-glutamine and 10% fetal bovine serum
Culture ConditionsAtmosphere: Air, 95%; CO2, 5%;Temperature: 37°C
CryopreservationFrozen with 70% medium, 20% FBS, 10% DMSO

The above is only part of a part of cell line products. If you don't find the cell line you want, Creative Biogene can also provide stable cell line generation service with the best prices and fastest turnaround time for you! Contact us for more information or to request a quote.

* For research use only. Not intended for any clinical use.
Quick Inquiry